Imatinib mesylate
methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
Molecular Identity
Imatinib mesylate
methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
PubChem CID: 123596
Imatinib methanesulfonate is a methanesulfonate (mesylate) salt that is the monomesylate salt of imatinib. Used for treatment of chronic myelogenous leukemia and gastrointestinal stromal tumours. It has a role as an anticoronaviral agent, an antineoplastic agent, a tyrosine kinase inhibitor and an apoptosis inducer. It contains an imatinib.
2D Structure
Properties
C30H35N7O4S
Molecular Formula
589.70
Molecular Weight
g/mol
589.2471
Exact Mass
Da
149
TPSA
May have limited oral absorption
3
H-Bond Donors
10
H-Bond Acceptors
799
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Imatinib mesylate220127-57-1GleevecGlivecImatinib mesilateimatinib methanesulfonatesti-571Imatinib accordImatinib medacSTI 571Imatinib (as mesilate)NSC-716051QTI-571Imatinib methane sulfonateIMKELDI
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Imatinib mesylate
Loading drug network...